Cargando…
Biological function analysis of ARHGAP39 as an independent prognostic biomarker in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the most common subtype of liver cancer, with a high morbidity and low survival rate. Rho GTPase activating protein 39 (ARHGAP39) is a crucial activating protein of Rho GTPases, a novel target in cancer therapy, and it was identified as a hub gene for gastric cancer...
Autores principales: | Ding, Yongqi, Gong, Yiyang, Zeng, Hong, Zhou, Xuanrui, Yu, Zichuan, Pan, Jingying, Zhou, Minqin, Liu, Shiwen, Lai, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120899/ https://www.ncbi.nlm.nih.gov/pubmed/37059586 http://dx.doi.org/10.18632/aging.204635 |
Ejemplares similares
-
FARSB serves as a novel hypomethylated and immune cell infiltration related prognostic biomarker in hepatocellular carcinoma
por: Zhen, Jing, et al.
Publicado: (2023) -
Identified RP2 as a prognostic biomarker for glioma, facilitating glioma pathogenesis mainly via regulating tumor immunity
por: Gong, Yiyang, et al.
Publicado: (2023) -
Comprehensive analysis of prognostic value, relationship to cell cycle, immune infiltration and m6A modification of ZSCAN20 in hepatocellular carcinoma
por: Jiayu, Fang, et al.
Publicado: (2022) -
Correction for: Comprehensive analysis of prognostic value, relationship to cell cycle, immune infiltration and m6A modification of ZSCAN20 in hepatocellular carcinoma
por: Jiayu, Fang, et al.
Publicado: (2023) -
ZNF320 is a hypomethylated prognostic biomarker involved in immune infiltration of hepatocellular carcinoma and associated with cell cycle
por: Zhen, Jing, et al.
Publicado: (2022)